Publication:
Pharmacokinetic characterization of favipiravir in patients with COVID-19

dc.contributor.authorKOCAKAYA, DERYA
dc.contributor.authorTİGEN, ELİF
dc.contributor.authorAY, NADİYE PINAR
dc.contributor.authorGÜLHAN, REZZAN
dc.date.accessioned2022-03-23T12:21:57Z
dc.date.accessioned2026-01-11T06:24:37Z
dc.date.available2022-03-23T12:21:57Z
dc.date.issued2022
dc.identifier.doi10.1111/bcp.15227
dc.identifier.issn1365-2125
dc.identifier.pubmedPMID: 35014080
dc.identifier.urihttps://hdl.handle.net/11424/254683
dc.language.isoeng
dc.relation.ispartofBritish Journal of Clinical Pharmacology
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectCOVID
dc.subjectfavipiravir
dc.subjectpharmacokinetics
dc.subjecttherapeutic drug monitoring
dc.titlePharmacokinetic characterization of favipiravir in patients with COVID-19
dc.typearticle
dspace.entity.typePublication
oaire.citation.titleBritish Journal of Clinical Pharmacology

Files